Small molecule anion carriers facilitate lactate transport in model liposomes and cells.

Biochemistry Biological sciences Molecular biology Natural sciences

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
20 Oct 2023
Historique:
received: 22 05 2023
revised: 29 08 2023
accepted: 08 09 2023
medline: 4 10 2023
pubmed: 4 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

An excessive production of lactate by cancer cells fosters tumor growth and metastasis. Therefore, targeting lactate metabolism and transport offers a new therapeutic strategy against cancer, based on dependency of some cancer cells for lactate as energy fuel or as oncogenic signal. Herein we present a family of anionophores based on the structure of click-tambjamines that have proved to be extremely active lactate carriers across phospholipid membranes. Compound 1, the most potent lactate transmembrane carrier, was studied in HeLa cells. The use of a monocarboxylate transporters (MCTs) inhibitor proved that

Identifiants

pubmed: 37790273
doi: 10.1016/j.isci.2023.107898
pii: S2589-0042(23)01975-2
pmc: PMC10543179
doi:

Types de publication

Journal Article

Langues

eng

Pagination

107898

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

A patent application (P202330370) related to this work has been submitted.

Références

Front Oncol. 2019 Nov 01;9:1143
pubmed: 31737570
Clin Cancer Res. 2014 Feb 15;20(4):926-937
pubmed: 24277449
Chem Commun (Camb). 2020 Nov 25;56(91):14137-14153
pubmed: 33057487
Oncotarget. 2015 Aug 7;6(22):19177-89
pubmed: 26203664
Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):349-53
pubmed: 11567808
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
Cancer Res. 2000 Feb 15;60(4):916-21
pubmed: 10706105
Cancer Res. 2014 Feb 1;74(3):908-20
pubmed: 24285728
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
pubmed: 18156677
Chem Soc Rev. 2010 Apr;39(4):1262-71
pubmed: 20349532
J Clin Invest. 2013 Sep;123(9):3685-92
pubmed: 23999443
Chem Commun (Camb). 2020 Mar 12;56(21):3218-3221
pubmed: 32073062
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Chem Soc Rev. 2011 Mar;40(3):1305-23
pubmed: 21125111
Chem Commun (Camb). 2013 Jan 11;49(3):246-8
pubmed: 23175428
Chem Soc Rev. 2020 Jul 21;:
pubmed: 32692794
Biomedicines. 2022 Apr 12;10(4):
pubmed: 35453638
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 03;369(1638):20130099
pubmed: 24493747
Acta Crystallogr A Found Adv. 2015 Jan;71(Pt 1):3-8
pubmed: 25537383
Pharmacol Rev. 2020 Apr;72(2):466-485
pubmed: 32144120
Sci Rep. 2018 Feb 8;8(1):2608
pubmed: 29422673
Chembiochem. 2021 Oct 13;22(20):2925-2940
pubmed: 34043277
Chem Sci. 2016 Feb 1;7(2):1600-1608
pubmed: 29899901
Cancers (Basel). 2020 Nov 03;12(11):
pubmed: 33153193
Br J Pharmacol. 2019 Jun;176(11):1764-1779
pubmed: 30825185
Chem Commun (Camb). 2019 Aug 20;55(68):10080-10083
pubmed: 31380526
Front Oncol. 2020 Mar 18;10:231
pubmed: 32257942
J Appl Crystallogr. 2015 Jan 30;48(Pt 1):3-10
pubmed: 26089746
Cancers (Basel). 2022 Jul 12;14(14):
pubmed: 35884450
Redox Biol. 2020 Aug;35:101454
pubmed: 32113910
Am J Cancer Res. 2018 Oct 01;8(10):1967-1976
pubmed: 30416849
AAPS J. 2019 Jan 7;21(2):13
pubmed: 30617815
J Oncol. 2019 Nov 3;2019:2084195
pubmed: 31781212

Auteurs

Daniel Alonso-Carrillo (D)

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.

Alain Arias-Betancur (A)

Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907, Spain.
Molecular Signalling, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.
Department of Integral Adult Dentistry, Dental School, Research Centre for Dental Sciences, Universidad de La Frontera, Temuco 4811230, Chile.

Israel Carreira-Barral (I)

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.

Pere Fontova (P)

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.

Vanessa Soto-Cerrato (V)

Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907, Spain.
Molecular Signalling, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.

María García-Valverde (M)

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.

Ricardo Pérez-Tomás (R)

Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907, Spain.
Molecular Signalling, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908, Spain.

Roberto Quesada (R)

Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.

Classifications MeSH